• 2009

Company Description

IgY Immune Technologies Life Sciences engages in the extraction of polyclonal antibodies for nutraceutical and pharmaceutical applications.

IGY Immune Technologies & Life Sciences Inc. engages in the extraction of polyclonal antibodies for nutraceutical and pharmaceutical applications for human and animal consumption. Its antibodies are derived from chicken eggs. The company’s products are used in medicines, functional foods, agriculture/feeds, and cosmeceuticals. IGY Immune Technologies & Life Sciences Inc. was founded in 2009 and is based in Thunder Bay, Canada.